Perhaps. I'm just asking the simple question based on a statement posted here today. Do you think zero placebo patients will show improvement? Do you think patients in the placebo group will be on other AD meds? Do you think when a trial doesn't proclude things, that means those things won't be present? Facetious I suppose.
Bizarre to me some of the issues aren't understood. Kind of like set theory I hear. As Investor says, and you suggest, we'll get trial data soon enough. Maybe it will be good enough where even lack of understanding won't matter.
Market Data 
Markets 
AI
